全文获取类型
收费全文 | 4488篇 |
免费 | 288篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 132篇 |
妇产科学 | 128篇 |
基础医学 | 791篇 |
口腔科学 | 75篇 |
临床医学 | 454篇 |
内科学 | 805篇 |
皮肤病学 | 157篇 |
神经病学 | 542篇 |
特种医学 | 148篇 |
外科学 | 326篇 |
综合类 | 41篇 |
一般理论 | 3篇 |
预防医学 | 335篇 |
眼科学 | 70篇 |
药学 | 391篇 |
中国医学 | 41篇 |
肿瘤学 | 318篇 |
出版年
2023年 | 37篇 |
2022年 | 35篇 |
2021年 | 178篇 |
2020年 | 107篇 |
2019年 | 167篇 |
2018年 | 146篇 |
2017年 | 106篇 |
2016年 | 150篇 |
2015年 | 147篇 |
2014年 | 212篇 |
2013年 | 250篇 |
2012年 | 430篇 |
2011年 | 452篇 |
2010年 | 252篇 |
2009年 | 172篇 |
2008年 | 341篇 |
2007年 | 315篇 |
2006年 | 269篇 |
2005年 | 240篇 |
2004年 | 201篇 |
2003年 | 171篇 |
2002年 | 157篇 |
2001年 | 33篇 |
2000年 | 21篇 |
1999年 | 36篇 |
1998年 | 27篇 |
1997年 | 16篇 |
1996年 | 10篇 |
1995年 | 12篇 |
1994年 | 14篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1971年 | 3篇 |
1934年 | 2篇 |
排序方式: 共有4801条查询结果,搜索用时 15 毫秒
1.
Bielik Peter Bonczek Ondřej Krejčí Přemysl Zeman Tomáš Izakovičová-Hollá Lydie Šoukalová Jana Vaněk Jiří Vojtěšek Bořivoj Lochman Jan Balcar Vladimir J. Šerý Omar 《Clinical oral investigations》2022,26(12):7045-7055
Clinical Oral Investigations - The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of... 相似文献
2.
3.
4.
Jana Regis Novaes Luise Ribeiro Daltro Thiago Amparo Ferreira Paulo Roberto Lima Machado 《Anais brasileiros de dermatologia》2022,97(1):89-92
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down syndrome had had verrucous plaques on the back for over a year, with progressive growth. PCR of a lesion sample was positive for Leishmania braziliensis. The patient's condition was classified as atypical cutaneous leishmaniasis. He was successfully treated with amphotericin B and miltefosine. The treatment remains a challenge, given the toxicity and low cure rate of the currently recommended drugs. 相似文献
5.
6.
Key Jana Maletzko Antonia Kohli Aneesha Gispert Suzana Torres-Odio Sylvia Wittig Ilka Heidler Juliana Bárcena Clea López-Otín Carlos Lei Yuanjiu West A. Phillip Münch Christian Auburger Georg 《Neurogenetics》2020,21(3):187-203
neurogenetics - Human RNF213, which encodes the protein mysterin, is a known susceptibility gene for moyamoya disease (MMD), a cerebrovascular condition with occlusive lesions and compensatory... 相似文献
7.
Kubeek Ondej Martnkov Jiina Chldek Jaroslav Blha Milan Malkov Jana Hodek Miroslav paek Ji Filip Stanislav 《Cancer chemotherapy and pharmacology》2020,85(2):353-365
Cancer Chemotherapy and Pharmacology - The present study evaluates the safety and efficacy of double-plasma filtration (PF) to remove the exceeding pegylated liposomal doxorubicin (PLD) in... 相似文献
8.
Jana Zdarova Karasova Milos Hroch Miroslav Pohanka Vendula Hepnarova Jaroslav Pejchal 《Toxin reviews》2020,39(2):138-146
AbstractPyridostigmine bromide acts as a reversible cholinesterase inhibitor that is used at relatively high doses in treatment of Myasthenia gravis and in low dose regimens as prophylaxis against nerve agents poisoning during the Gulf War. The manifestation of late nonspecific symptoms commonly called Gulf War illness has led to the discussion about the role of pyridostigmine bromide in the pathogenesis of this illness. In our study, we described plasma absorption profile of pyridostigmine bromide after p.o. administration in rats; subsequently, changes in blood biochemical and oxidative stress markers were measured. Pyridostigmine bromide was applied p.o. at the dose of 5.82?mg/kg b.w. according to the previously published recommendations. The absorption of pyridostigmine was relatively fast; the Cmax in plasma was 110.20?±?15.12?ng/ml at Tmax of 197.12?±?17.14?min. The bioavailability expressed as AUCtotal was 44,348?±?7608?min ng/ml. The prolongation of pyridostigmine in circulation is in agreement with relatively long half-life that was 179.00?±?28.54?min. Several blood biochemical markers were altered, including glucose, creatinine, creatine kinase, alanine aminotransferase, aspartate aminotransferase, interleukin-6, triglycerides, and cholesterol. However, the changes could be considered as mild. Thiobarbituric acid reactive substances and ferric reducing ability of plasma indicate suppression of basal metabolism. The results of blood biochemical and oxidative stress markers imply that long-term use might possibly change the basal metabolism and cause cellular damage with inflammatory changes. 相似文献
9.
10.